JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 16, 2004; DOI: 10.1124/jpet.103.060574


0022-3565/04/3092-697-704$20.00
JPET 309:697-704, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.060574v1
309/2/697    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hou, C.
Right arrow Articles by Cavender, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hou, C.
Right arrow Articles by Cavender, D.

INFLAMMATION AND IMMUNOPHARMACOLOGY

In Vivo Activity of a Phospholipase C Inhibitor, 1-(6-((17{beta}-3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in Acute and Chronic Inflammatory Reactions

Cuifen Hou, Thomas Kirchner, Monica Singer, Michele Matheis, Dennis Argentieri, and Druie Cavender

Department of Drug Discovery, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan, New Jersey

To investigate the role of phospholipase C (PLC) in inflammatory processes, we tested 1-(6-((17{beta}-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), a widely used PLC inhibitor, in several in vitro and in vivo assays. We first examined the effects of U73122 on human phospholipase C-{beta} (PLC-{beta}) isozymes and found that U73122 significantly inhibited recombinant human PLC-{beta}2, with an IC50 of ~6 µM. U73122 had little effect on PLC-{beta}1, PLC-{beta}3, or PLC-{beta}4. Consistent with its ability to inhibit PLC-{beta}2 enzymatic activity, U73122 reduced interleukin-8 and leukotriene B4-induced Ca2+ flux and chemotaxis in human neutrophils in a concentration-dependent manner. In vivo, U73122 blocked carrageenan-induced hind paw edema in rats, carrageenan-induced macrophage and lymphocyte accumulation into subcutaneous chambers in dogs, lipopolysaccharide-induced macrophage, lymphocyte infiltration and prostaglandin E2 production in a mouse peritonitis model, and 12-O-tetradecanoylphorbol-13-acetate-induced ear edema in mice. These results implicate PLC-dependent signaling pathways in the development of acute and chronic inflammatory responses in vivo.


Received September 26, 2003; accepted December 22, 2003.

Address correspondence to: Dr. Cuifen Hou, Johnson and Johnson Pharmaceutical Research and Development, L.L.C., Drug Discovery, 1000 Route 202, Rm B-110, P.O. Box 300, Raritan, NJ 08869. E-mail: chou{at}prdus.jnj.com




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
V. Kolsch, P. G. Charest, and R. A. Firtel
The regulation of cell motility and chemotaxis by phospholipid signaling
J. Cell Sci., March 1, 2008; 121(5): 551 - 559.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Poeckel, L. Tausch, S. George, J. Jauch, and O. Werz
3-O-Acetyl-11-keto-boswellic Acid Decreases Basal Intracellular Ca2+ Levels and Inhibits Agonist-Induced Ca2+ Mobilization and Mitogen-Activated Protein Kinase Activation in Human Monocytic Cells
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 224 - 232.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Feisst, L. Franke, G. Appendino, and O. Werz
Identification of Molecular Targets of the Oligomeric Nonprenylated Acylphloroglucinols from Myrtus communis and Their Implication as Anti-Inflammatory Compounds
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 389 - 396.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Feisst, D. Albert, D. Steinhilber, and O. Werz

Mol. Pharmacol., May 1, 2005; 67(5): 1751 - 1757.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Basset, F.-X. Boittin, O. M. Dorchies, J.-Y. Chatton, C. van Breemen, and U. T. Ruegg
Involvement of Inositol 1,4,5-Trisphosphate in Nicotinic Calcium Responses in Dystrophic Myotubes Assessed by Near-plasma Membrane Calcium Measurement
J. Biol. Chem., November 5, 2004; 279(45): 47092 - 47100.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.